HemaClear Tourniquet Email

Provides A Sterile & Bloodless Surgical Field . OHK Medical Devices

Current Roles

Employees:
37
Revenue:
$9.3M
About
OHK Medical Devices, Inc. develops and manufactures surgical tourniquets under the HemaClear brand (www.hemaclear.com). HemaClear helps prepare patients for any orthopedic procedure in just 12 seconds. With more than 500,000 procedures performed to date, the tourniquet is becoming a standard of care in operating rooms in many countries. It is regularly used in leading hospitals such as The Hospital for Special Surgery in New York, Sinai Hospital of Baltimore, and the Shriners Hospitals for Children. HemaClear exsanguinating tourniquets are unique: • No blood leaks – The device exsanguinates more than 95% blood from the extremity. • Offers a wider surgical field – Surgery is easier to perform as the narrow profile of the device offers maximal exposure of the surgery area. • Sterile, single use – Sterility is ensured100% of the time. This eliminates the need for any reprocessing. • Ready to go in seconds – Only seconds to apply. Training takes minutes. • Cost effective – No need for bulky equipment, making use extremely economical. For more information or to schedule your free evaluation, contact us at: info@hemaclear.com
OHK Medical Devices Address
2885 Sanford Ave. SW #14751
Grandville, MI
United States
OHK Medical Devices Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.